Background Gastrointestinal stromal tumors (GISTs) are the most common gastrointestinal mesenchymal neoplasms which can arise from any part of the gastrointestinal tract (GIT) or an extraintestinal location. Size and the organ of origin are the major imaging inputs expected from the radiologist. However, it is worthwhile to find out which imaging characteristics on MDCT correlate with risk stratification. This knowledge would help the clinician in treatment planning and prognostication. The aim of this retrospective study is to evaluate the various MDCT imaging characteristics of GISTs and find out which parameters have significant association with risk and subsequent development of metastasis on follow-up whenever it was possible. Materials and Methods This is a retrospective study conducted on 45 histopathologically proven cases of GIST from two institutions by searching from the digital archives. The following imaging parameters were analyzed: maximum size in any plane, organ of origin, shape (round, ovoid or irregular), margin (well-defined or ill-defined), surface (smooth or lobulated), percentage of necrosis, growth pattern, enhancement characteristics–both intensity (mild, moderate or significant) and pattern (homogenous vs. heterogenous), calcification, infiltration into adjacent organs, and presence of metastasis at presentation or on follow-up. Results CT morphological parameters of significance in risk stratification as per our study include tumor necrosis, predominant cystic change, irregular and lobulated shape/surface characteristics, and adjacent organ infiltration.The parameters which were associated with development of metastasis were size > 5 cm, necrosis > 30%, and the presence of adjacent organ infiltration. Conclusion The radiologist has an important role in ascertaining the size of tumor as well as the organ of origin accurately to guide the clinician in risk calculation and subsequent prognostication. In addition, certain CT characteristics mentioned above, namely, tumor size, significant necrosis/cystic changes, irregular/lobulated contour, and invasion of adjacent organs, help in risk stratification and in predicting metastasis/poor prognosis.
Introduction: The introduction of Multi-Detector Computed Tomography (MDCT) has revolutionised clinical practice. Mediastinal lesions represent challenging problems faced by the radiologist and often a chest radiograph is inadequate for answering the queries of clinicians. MDCT is employed to diagnose various causes of mediastinal widening and often correct diagnosis is obtained using CT alone, thus obviating invasive diagnostic procedures. Aim: To assess the diagnostic accuracy of MDCT in mediastinal mass lesions compared to histopathology. Materials and Methods: A prospective observational study comprised of 52 patients who underwent MDCT examination for evaluation of mediastinal masses. All these patients subsequently underwent histopathological examination either by CT-guided biopsy, transthoracic needle aspiration, endoscopic biopsy or by surgical resection. Sensitivity, specificity and accuracy of each type of lesion was calculated and tabulated. Results: The study population comprised of 52 patients out of whom 43 cases (83%) were predicted correctly by CT when compared with histopathology diagnosis. The sensitivity of detecting malignancy was 100% and specificity was 92.6%. The present study had accuracy of 96.2% in differentiating malignant mediastinal masses from benign lesions. Conclusion: MDCT is useful in evaluating the distribution of mediastinal masses and their relationship to adjacent structures and differentiating between malignant mediastinal masses from benign lesions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.